Study to Assess the Efficacy and Safety of Garetosmab in Japanese Adult Patients With Fibrodysplasia Ossificans Progressiva (FOP)

Clinical trial NCT04577820 · WITHDRAWN

Trial details

NCT number: NCT04577820
Sponsor: Regeneron Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Fibrodyplasia Ossificans Progressiva (FOP)Heterotopic Ossification (HO)

Start date: 2021-10-13
Primary completion: 2022-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.